Consistent with previous findings, our study revealed that pharmacologically induced CXCR2 LOF with navarixin exhibited increased susceptibility to Streptococcus pneumoniae infection, evidenced by increased bacterial load in the lungs, elevated mortality, and decreased overall survival. This evidence concerns the gene CXCR2 and pneumococcal infection.